genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2013
Sexual dysfunction
News
Coming Sooner: Generic Viagra’s U.S. Launch Set for 2017 as Teva, Pfizer Settle Lawsuit
News
Innovus Wins License to Market Sexual Dysfunction Drug in Morocco
Cancer
Finasteride Cuts Prostate Cancer Risk; No Lifespan Impact
News
Softening the Blow from FOLFOX Treatment
News
Female Sexual Dysfunction Drugs
News
Phase I Anti-Obesity Candidate Dropped on Safety Grounds
News
BioSante, Teva Win FDA Nod for Male Hypogonadism Therapy
News
Phase III Study Shows Ampio Drug Improves Ejaculation Times in Men with PE
Industry News
BioSante Expects to Obtain $23.8M to Advance Treatment for Female Sexual Disorders
Industry News
Palatin Obtains $21.1M to Advance Programs in Female Sexual Dysfunction and Asthma
1
2
Page 1 of 2
Scroll Up
Scroll Up
